BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 9315472)

  • 1. IFN-gamma inducibility of class II transactivator is specifically lacking in human tumour lines: relevance to retinoblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes.
    Lu Y; Tschickardt ME; Schmidt BJ; Blanck G
    Immunol Cell Biol; 1997 Aug; 75(4):325-32. PubMed ID: 9315472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction.
    Lu Y; Boss JM; Hu SX; Xu HJ; Blanck G
    J Immunol; 1996 Apr; 156(7):2495-502. PubMed ID: 8786310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor lines.
    Tschickardt ME; Lu Y; Jacim M; Ussery GD; Steimle V; Mach B; Blanck G
    Int J Cancer; 1995 Aug; 62(4):461-5. PubMed ID: 7635572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for retinoblastoma protein (RB) dependent and independent IFN-gamma responses: RB coordinately rescues IFN-gamma induction of MHC class II gene transcription in noninducible breast carcinoma cells.
    Lu Y; Ussery GD; Muncaster MM; Gallie BL; Blanck G
    Oncogene; 1994 Apr; 9(4):1015-9. PubMed ID: 8134104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
    Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
    J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D3 reduces the apoptotic effect of IFN-gamma but does not facilitate HLA class II inducibility in RB-defective cells.
    Schmidt B; Carter SS; Berry DE; Blanck G
    Cancer Lett; 1996 Dec; 110(1-2):169-76. PubMed ID: 9018097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.
    Rodríguez T; Méndez R; Del Campo A; Aptsiauri N; Martín J; Orozco G; Pawelec G; Schadendorf D; Ruiz-Cabello F; Garrido F
    Immunogenetics; 2007 Feb; 59(2):123-33. PubMed ID: 17180681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
    Meissner M; Whiteside TL; Kaufmann R; Seliger B
    Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines.
    van der Stoep N; Biesta P; Quinten E; van den Elsen PJ
    Int J Cancer; 2002 Feb; 97(4):501-7. PubMed ID: 11802213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
    Murphy SP; Tomasi TB
    Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-gamma and tumor necrosis factor-alpha in human thyroid carcinoma cells.
    Rahat MA; Chernichovski I; Lahat N
    Int Immunol; 2001 Nov; 13(11):1423-32. PubMed ID: 11675374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells.
    Liu A; Takahashi M; Toba K; Zheng Z; Hashimoto S; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    Hematol Oncol; 1999 Dec; 17(4):149-60. PubMed ID: 10725870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.
    Chin KC; Mao C; Skinner C; Riley JL; Wright KL; Moreno CS; Stark GR; Boss JM; Ting JP
    Immunity; 1994 Nov; 1(8):687-97. PubMed ID: 7600294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
    Croce M; De Ambrosis A; Corrias MV; Pistoia V; Occhino M; Meazza R; Giron-Michel J; Azzarone B; Accolla RS; Ferrini S
    Oncogene; 2003 Oct; 22(49):7848-57. PubMed ID: 14586411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of CIITA promoter IV causes loss of HLA-II inducibility by IFN-gamma in promyelocytic cells.
    De Lerma Barbaro A; De Ambrosis A; Banelli B; Li Pira G; Aresu O; Romani M; Ferrini S; Accolla RS
    Int Immunol; 2008 Nov; 20(11):1457-66. PubMed ID: 18829986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential selectivity of CIITA promoter activation by IFN-gamma and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-alpha.
    Nikcevich KM; Piskurich JF; Hellendall RP; Wang Y; Ting JP
    J Neuroimmunol; 1999 Oct; 99(2):195-204. PubMed ID: 10505975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.
    Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS
    Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell line.
    Osborne AR; Zhang H; Blanck G
    Mol Immunol; 2006 Feb; 43(6):710-6. PubMed ID: 16360016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas.
    Kanaseki T; Ikeda H; Takamura Y; Toyota M; Hirohashi Y; Tokino T; Himi T; Sato N
    J Immunol; 2003 May; 170(10):4980-5. PubMed ID: 12734341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN-gamma).
    Kadota Y; Okumura M; Miyoshi S; Kitagawa-Sakakida S; Inoue M; Shiono H; Maeda Y; Kinoshita T; Shirakura R; Matsuda H
    Clin Exp Immunol; 2000 Jul; 121(1):59-68. PubMed ID: 10886240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.